Investigating a new approach to care for people with musculoskeletal chest pain: A randomised controlled feasibility trial

niversity of Otago0 个研究点目标入组 26 人开始时间: 2024年4月19日最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•Presents to ED with an acute episode of chest pain AND receives a primary diagnosis of suspected musculoskeletal chest pain
•Age 16 years or over
•History consistent with musculoskeletal causes (e.g., onset, activity- or position-dependent chest pain)
•Evidence of musculoskeletal dysfunction on physical examination; (i.e., pain reproduction on palpation of sternocostal joint(s) or with deep breathing; pain reproduction and/or restriction with thoracic spine range of motion)
•Able to provide informed consent
•Able to speak and understand English

•Non-mechanical, potentially serious sources of chest pain (e.g., cardiac, respiratory, infectious, systemic inflammatory, neoplastic processes, other priority non-musculoskeletal pain) as diagnosed by a medical practitioner.
•Chronic overlapping pain conditions diagnosed by a medical practitioner as listed in the Central Sensitisation Inventory, Part B (e.g., restless leg syndrome, chronic fatigue syndrome, fibromyalgia, temporomandibular joint disorder, migraine or tension headaches, irritable bowel syndrome, multiple chemical sensitivities, neck injury (including whiplash), anxiety or panic attacks, depression (Mayer et al., 2012).
•History of fractures or surgery to the chest and thoracic region (e.g., sternotomy), in the past six months.
•Currently receiving treatment involving opioids and/or corticosteroids.

发起方